UMP (00722) announces its interim financial results with a net profit attributable to shareholders of HKD 18.392 million, an increase of 2.47% year-on-year.
Union Medical (00722) released its interim results for the six months ending on December 31, 2025. The group achieved a revenue of 368 million Hong Kong dollars, a decrease of 1% year-on-year. The net profit attributable to the owners of the company was 18.392 million Hong Kong dollars, an increase of 2.47% year-on-year. Earnings per share were 2.36 Hong Kong cents. It is proposed to distribute an interim dividend of 1.4 Hong Kong cents per share.
UMP (00722) releases its interim results for the six months ended December 31, 2025. The group achieved a revenue of HK$368 million, a decrease of 1% compared to the same period last year. The attributable profit to owners of the company was HK$18.392 million, a 2.47% increase compared to last year, with earnings per share of 2.36 HK cents. The company plans to distribute an interim dividend of 1.4 HK cents.
The announcement stated that the overall decrease in revenue by 1.0% was mainly due to a decrease in clinical healthcare revenue in Hong Kong, Macau, and mainland China.
Related Articles

Muyuan Foods (02714) intends to change its name to "Muyuan Food Group Limited".

NUR Holdings (00254) releases interim results, with shareholders' net loss expanding by 22.34% to HK$23.535 million compared to the same period last year.

US Stock Market Move | Gold and silver stocks rose before the market opened, with First Majestic Silver (AG.US) up more than 3%.
Muyuan Foods (02714) intends to change its name to "Muyuan Food Group Limited".

NUR Holdings (00254) releases interim results, with shareholders' net loss expanding by 22.34% to HK$23.535 million compared to the same period last year.

US Stock Market Move | Gold and silver stocks rose before the market opened, with First Majestic Silver (AG.US) up more than 3%.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


